Stephen B. Solomon

Suggest Changes
Learn More
BACKGROUND The epidermal growth factor receptor (EGFR) mutation T790M is reported in approximately 50% of lung cancers with acquired resistance to EGFR inhibitors and is a potential prognostic and(More)